Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating sifalimumab in adults with systemic lupus erythematosus has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Sifalimumab (sifalimumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2016-07-11